Biora Therapeutics Inc logo

Biora Therapeutics Inc

NEW
OTCPK:BIORQ (USA)   Ordinary Shares
$ 0.22 (0%) 10:08 PM EST
At Loss
Market Cap:
$ 995.00K
Enterprise V:
$ 37.45M
Volume:
0
Avg Vol (2M):
0
Trade In:
Volume:
0
At Loss
Avg Vol (2M):
0

Business Description

Biora Therapeutics Inc logo
Biora Therapeutics Inc
NAICS : 541714 SIC : 2833
ISIN : US74319F3055

Share Class Description:

BIORQ: Ordinary Shares
Description
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History
FCF Margin %
-5179.71
OCF Margin %
-5148.32
Name Current Vs Industry Vs History
EV-to-Forward-Revenue
7.49

Financials (Next Earnings Date:2026-09-07 Est.)

BIORQ's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:BIORQ

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2026
2025
2024
2023
2022
2021
2020
2019
2018
2017

Biora Therapeutics Inc Executives

Details

GF Valueâ„¢

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.892
EPS (TTM) ($) -13.04
Beta 1.06
3-Year Sharpe Ratio -1.41
3-Year Sortino Ratio -1.38
Volatility % -
14-Day RSI -
14-Day ATR ($) -
20-Day SMA ($) 0.22
12-1 Month Momentum % -
52-Week Range ($) 0.22 - 0.22
Shares Outstanding (Mil) 4.52

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biora Therapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Biora Therapeutics Inc Stock Events

Financials Calendars
Event Date Price ($)
Fourth quarter earnings results for 2026 2027-02-02 In 149 days
Fourth quarter earnings conference call for 2026 2027-02-02 In 149 days
Third quarter earnings results for 2026 2026-11-13 In 68 days
Third quarter earnings conference call for 2026 2026-11-13 In 68 days
General meeting for 2025 2026-09-10 In 4 days
Second quarter earnings conference call for 2026 2026-09-07 In 1 day
Second quarter earnings results for 2026 2026-09-07 In 1 day
Third quarter earnings conference call for 2024 2024-11-14 16:30 2.49 (-7.78%)
Third quarter earnings results for 2024 2024-11-14 2.49 (-7.78%)
0.1:1 Stock Split 2024-10-18 5.54 (-4.02%)
Show
Entries

Biora Therapeutics Inc Frequently Asked Questions

What is Biora Therapeutics Inc(BIORQ)'s stock price today?
The current price of BIORQ is $0.22. The 52 week high of BIORQ is $0.22 and 52 week low is $0.22.
When is next earnings date of Biora Therapeutics Inc(BIORQ)?
The next earnings date of Biora Therapeutics Inc(BIORQ) is 2026-09-07 Est..
Does Biora Therapeutics Inc(BIORQ) pay dividends? If so, how much?
Biora Therapeutics Inc(BIORQ) does not pay dividend.

Guru Commentaries on OTCPK:BIORQ

No fund manager commentary yet.

Press Release

Subject Date
Thinking about buying stock in Safe & Green Development, Biora Therapeutics, Enphase Energy, GigaCloud Technology, or Fisker? 2023-12-01
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Biora Therapeutics, Inc. - BIOR 2023-11-03
PROGENITY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Progenity, Inc. - PROG 2021-06-25
PROGENITY INVESTIGATION INITIATED By Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Progenity, Inc. - PROG 2021-06-11
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG 2021-03-03
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG 2021-02-19
PROG Deadline Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Progenity, Inc. Investors of Class Action and Lead Plaintiff Deadline: October 27, 2020 2020-10-23
PROG INVESTOR FILING DEADLINE: Bernstein Liebhard LLP Reminds Investors That Only 7 Days Remain to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Progenity, Inc. 2020-10-20
Deadline Reminder: The Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Progenity, Inc. (PROG) 2020-10-20
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Progenity, Inc. - PROG 2020-10-17
10/Page

Articles on Biora Therapeutics Inc

No articles.

Headlines

See More
  • 1
No news.
  • 1